SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

EQ

Equillium, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed8d 14h ago SEC0001011438-26-000692
Passive stake amendment
Actionable Insight • Neutral

Affinity's stake is below 5% and passive, so no immediate catalyst. Monitor whether the fund increases its position above 5% in future filings, which could signal growing conviction.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$1.15
T+0 close · Nov 13, 2026 · via day close
Latest settled
+5.22%
T+1 · $1.21 · next T+5 in 24h
Vs SPY
+6.23%
α at T+1
Latest observation
−10.38%
T+4 · FF3 residual α
  1. T+0 · Nov 16 $1.15entry
  2. T+1 · 5d ago +5.22%α +6.23% · $1.21
  3. T+4 · todayOpen
  4. T+5 · in 24h Pending
  5. T+20 · in 23d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Affinity Asset Advisors filed an amended Schedule 13G disclosing a 4.1% passive stake in Equillium as of September 30, 2026, representing 2,613,954 shares. This is a new passive disclosure below the 5% threshold, with no change in investment intent indicated.

Key Financial Metrics

Stake
4.1%
Investor
Affinity Asset Advisors, LLC
Investor Type
hedge fund

Key Facts

  • Affinity Asset Advisors disclosed beneficial ownership of 2,613,954 shares of Equillium common stock as of September 30, 2026
  • Stake represents approximately 4.1% of shares outstanding based on 63,408,082 shares outstanding as of August 7, 2026
  • Filing is an amendment to Schedule 13G, confirming passive investment intent
  • Shares are held directly by Affinity Healthcare Fund, LP, with Affinity Asset Advisors as investment manager

Financial Impact

2,613,954 shares valued at approximately $4.5M based on $111M market cap and 63.4M shares outstanding

ownership

Risk Factors

  • No material risks identified from this routine passive disclosure

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001011438-26-000692
Document: 0001011438-26-000692-index.html0001011438-26-000692
Document: 0001011438-26-000692.txt0001011438-26-000692

Track record

20 reports on EQ

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +20.40% at T+60 after the Jun 5, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 20, 20262d ago EFFECT Neutral 4/10 Entry $1.12 Now $1.06 −5.36% settles Nov 23
  2. Nov 16, 20265d ago SC 13G/A Neutral 3/10 Entry $1.21 to $1.10 Now $1.06 −12.40% ▼ −9.09% −8.79% vs SPY
  3. Nov 13, 20268d ago SC 13G/A Neutral 2/10 Viewing Entry $1.15 to $1.21 Now $1.06 −7.83% ▲ +5.22% +6.23% vs SPY
  4. Nov 12, 20269d ago S-3 Neutral 4/10 Entry $1.29 to $1.15 Now $1.06 −17.83% ▼ −10.85% −8.94% vs SPY
  5. Nov 12, 20269d ago 8-K Neutral 5/10 Entry $1.29 to $1.15 Now $1.06 −17.83% ▼ −10.85% −8.94% vs SPY
  6. Nov 12, 20269d ago SC 13G/A Neutral 2/10 Entry $1.32 to $1.29 Now $1.06 −19.70% ▼ −2.27% −1.91% vs SPY
  7. Nov 4, 202617d ago SC 13G/A Neutral 2/10 Entry $1.40 to $1.33 Now $1.06 −24.29% ▼ −5.00% −0.59% vs SPY
  8. Oct 26, 202626d ago 8-K Bearish 6/10 Entry $1.36 to $1.42 Now $1.06 +22.06% ▼ −4.41% −4.07% vs SPY
  9. Oct 26, 202626d ago Press Release Neutral 4/10 Entry $1.25 to $1.36 Now $1.06 −15.20% ▲ +8.80% +8.24% vs SPY
  10. Oct 5, 20266w ago 8-K Neutral 3/10 Entry $1.42 to $1.39 Now $1.06 −25.35% ▼ −2.11% −1.87% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens Mon (26h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026